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CASE REPORT

MUMPS MYOCARDITIS: A FORGOTTEN DISEASE?
Sheraz Hussain, Mohammad Faizan Zahid, Arshalooz Jamila Rahman*, Mehnaz Atiq
Ahmed*, Shahnaz Hamid Ibrahim*
Medical College, Aga Khan University, Karachi, *Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan

Mumps is an acute viral illness that follows a self-limiting course but up to 10% of cases have a
complicated course with the involvement of other organ systems. Myocarditis is reported as a
complication but the incidence has greatly fallen ever since the development of the mumps vaccine. A
child presented to our department with parotid swelling and fever. Persistent tachycardia with irregular
pulse led to further cardiac work up which showed decreased ejection fraction and raised serum cardiac
enzymes, indicating myocardial damage. With ionotropic agents and supportive care, there was
complete normalization of ejection fraction and serum cardiac enzyme levels. He was discharged
within a week of admission. This case highlights the importance of suspecting myocarditis in the setting
of mumps, a diagnosis that precludes early suspicion in mumps patients suffering from cardiac
symptoms not explained by other potential aetiologies. Early suspicion and timely supportive care are
essential to ensure favourable outcomes.
Keywords: Mumps, Myocarditis, Parotitis, Viral Parotitis
J Ayub Med Coll Abbottabad 2016;28(1):201–3

INTRODUCTION

CASE REPORT

Mumps is an acute viral illness caused by the mumps
virus, which belongs to the Paramyxoviridae family
of viruses.1 It is predominantly a disease of
childhood, typically characterized by painful swelling
of the parotid gland in majority of cases,
accompanied by fever, malaise and anorexia.1,2
Mumps is known to follow a self-limiting course and
is known to be a benign disease when compared with
other vaccine-preventable diseases such as measles,
pertussis etc.1–3 Nevertheless, the burden of the
disease should not be underestimated, as up to 10%
of the diseases are reported to run a complicated
course because of the involvement various organ
systems, some of which include, but are not limited
to, aseptic meningoencephalitis, pancreatitis,
sensorineural hearing loss, orchitis (males) and
oophoritis (females).1,3–5
Myocarditis, however, is a rare complication
of this viral illness6–11, first reported by Pujol et al11
in 1918. The incidence of myocarditis as a
complication of mumps was reported to be as high as
15% in all cases in literature up until the mid1950s.6,10
With the introduction of the mumps vaccine
in the childhood vaccination schedules of numerous
countries in 1998, there has been a rapid decline in
the incidence of the disease;1 consequently, the
incidence of myocarditis has fallen to as low as 4%.
In some regions, the complications of mumps, such
as myocarditis, have almost completely vanished
ever since.1,3 We report the case of an 8 year old
child who presented with typical findings of
mumps
parotitis
along
with
myocardial
involvement.

An 8 year old boy presented to our emergency room
with a 3 day history of fever, abdominal pain,
bilateral cheek swelling and generalized body aches
and stiffness. He also had a one day history of up
rolling of eyes with jerky movements, most likely
suggesting seizures. Upon further inquiry, the child
had been diagnosed with mumps two days ago on
clinical grounds by a local paediatrician. Birth and
developmental histories were unremarkable. The
child had been vaccinated under the Expanded
Program on Immunization (EPI) schedule in
Pakistan, but had not received the measles, mumps,
and rubella (MMR) vaccine, since it was not included
in the EPI schedule. Family history was significant
for diabetes mellitus; otherwise no one in the family
was experiencing similar complaints. The local
paediatrician
prescribed
acetaminophen
for
symptomatic relief; however, his symptoms were not
improving.
Physical examination revealed a drowsy,
sick looking child with a Glasgow Coma Scale
(GCS) score of 9/15. There was painful swelling over
the parotid region bilaterally with enlarged
submandibular lymph nodes. Peripheral pulses were
weak with an irregular heart rate, reaching to a
maximum of 149 beats/minute and blood pressure of
92/60 mmHg. Motor system examination showed
increased muscle tone with decreased power (2/5)
and positive Babinski sign.
A provisional diagnosis of mumps
complicated with encephalitis was made. Noteworthy
differentials at the time were bacterial meningitis and
hyponatremic encephalopathy. The patient was
shifted to the intensive care unit and was started on
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intravenous (IV) fluids and empiric ceftriaxone and
vancomycin to cover bacterial meningitis. Complete
blood counts showed leukocytosis with neutrophilia
and lymphopenia. Other blood tests showed marked
hyponatremia and hypokalaemia (126 and 3.0
mEq/L, respectively). Lumbar puncture was
unremarkable for any cerebrospinal fluid (CSF)
abnormalities suggestive of meningitis, hence
antibiotics
were
discontinued.
An
electroencephalogram was ordered which revealed
theta and delta slowing with prominent sleep activity
in the absence of any definitive epileptic activity.
Phenobarbital was given as seizure prophylaxis. The
electrolyte imbalance was managed with hypertonic
saline which eventually resulted in clinical
improvement and a rise in the GCS score to 15/15
within the next 72 hours.
However, irregular pulse with tachycardia
persisted despite active medical management and
improvement. A cardiology consultation was sought,
who advised to get an echocardiogram,
electrocardiogram (ECG) and cardiac enzymes.
Echocardiogram revealed dilated left sided cardiac
chambers with grade 1 mild diastolic dysfunction and
atypical movement of the interventricular septum was
noted. Ejection fraction was noted to be low (35%).
Creatine kinase MB and troponin I were both
elevated (43.50 and 2.62 ng/ml, respectively)
indicative of myocardial damage, however, an ECG
done at that time did not show any findings consistent
with myocardial ischemia. A clinical diagnosis of
myocarditis secondary to mumps was made.
The child was started on inotropic support
with dopamine, dobutamine and digoxin. Enalipril,
spironolactone, L-carnitine and methylprednisolone
were also added and seizure prophylaxis was
continued. An order was placed for mumps
immunoglobulin from the National Institute of
Health, Islamabad. Unfortunately due to nonavailability, we were not able to obtain the
immunoglobulin to add to the patient’s therapy.
The child’s overall condition began to
improve, however, tachycardia persisted. A repeat
ECG was done, which indicated non-specific
anterolateral T wave changes suggestive of left
ventricular hypertrophy.
Over the course of next few days, continued use of
medicines led to further improvement of symptoms.
All serum electrolytes normalized, except for mild
hyponatremia (134 mEq/L). Tachycardia resolved
with the appearance of normal sinus rhythm. The
child was active, asymptomatic and GCS remained
stable at 15/15.
A repeat echocardiogram showed significant
improvement in cardiac function with an ejection
fraction of 66% and no evidence of diastolic
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dysfunction and cardiac enzyme levels had
normalized. Inotropic support was eventually
discontinued. In light of marked clinical
improvement, the child was discharged on the 7th
day of his admission. Mild hyponatremia persisted
and the child was advised to increase salt in the diet
and regular outpatient follow up.

DISCUSSION
Mumps is an acute viral illness of childhood,
characterized by painful swelling of the parotid gland
accompanied with fever, malaise and anorexia.1,2 It
follows a relatively benign and self-limiting course in
comparison to other vaccine-preventable diseases
such as measles, pertussis etc.1–3 but up to 10% of
cases have a complicated course with the
involvement of other organs such as the central
nervous system (CNS), pancreas etc.4 Up until the
mid-1950s, myocarditis was reported as a
complication in up to 15% of cases,6,10 but ever since
the incorporation of the mumps vaccine in
immunization schedules, the incidence has fallen to
as low as 4%, an even completely disappeared in
some regions.1,3
Our patient presented with a history of pain,
parotid swelling with fever and malaise; a very
typical presentation of mumps. The neurological
symptoms pointed towards CNS involvement and
possible viral encephalitis secondary to mumps,
which was ruled out by unremarkable CSF analysis.
Other blood work showed remarkable hyponatremia,
which could have been the most probable cause of
the patient’s neurological symptoms.
With improvement in GCS score and
resolution of neurological symptoms, the persistence
of irregular pulse with tachycardia led us to suspect
an underlying cardiac pathology. Low ejection
fraction on echocardiogram and elevated cardiac
enzymes pointed towards myocardial damage and
compromise; though an ECG done at the time was
inconclusive and did not show any signs of
myocardial ischemia. ECG abnormalities have been
demonstrated in patients with cardiac involvement as
a complication of mumps,4,6,10,12 ST segment and T
waves abnormalities being the most common ECG
findings2. However, no ECG findings were
demonstrated during active cardiac disease in our
patient.
Inotropic drugs, steroids and supportive care
led to eventual recovery of cardiac function and
resulted in a favourable outcome. The use of heart
failure medications such as diuretics, angiotensin
converting enzyme-inhibitors and β-blockers are the
mainstay of treatment of viral myocarditis. Patients
who have compromised left ventricular function
require ionotropic support for symptomatic relief.13–15
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Upon improvement in left ventricular function,
therapy can be discontinued, with several studies
showing favourable outcomes. Ionotropic agents and
supportive care can also be used as a bridge to heart
transplantation in the case of those patients who have
irreversibly compromised cardiac function.13–15 It is
important to recognize this complication early in
order to prevent development of any myocardial
residua. The damage is completely reversible in most
cases; though it may be prolonged and recovery
might be delayed if the problem is not recognized
early.4,7
Though the cardiac dysfunction is transient
in most cases, there have been cases in which mumps
myocarditis has resulted in a fatal outcome,8,9,16,17
highlighting the potentially deadly nature of this
complication. Rosenberg et al10, 12 have emphasized
upon the fact that mumps myocarditis is probably not
rare and thereby merits the need for further study.
The potential involvement of several organ systems
by the disease suggests that mumps is a generalized
viral process and that many organ systems, including
the cardiovascular system, may be affected by the
acute infectious process; such involvement may
remain subclinical or may develop clinically
significant signs and symptoms and may occur with
unpredictable frequency, depending on varying
severity from patient to patient. Review of literature
suggests that mumps myocarditis frequently goes
unrecognized and usually manifests in a subclinical
form.1,3,4,7 As previously discussed, a considerable
number of mumps myocarditis cases were reported
up until the mid-1950s, but over the years there has
been a gradual decline in reports of this complication
of mumps. To the best of our knowledge, there have
been no cases reported during the 21st century.
To conclude, though there has been a great
fall in the incidence of myocarditis secondary to
mumps in the recent decades, it is a noteworthy
complication of mumps. This case highlights the
importance of suspecting myocarditis in the setting of
mumps, a diagnosis that precludes early suspicion in
mumps patients suffering from cardiac symptoms not
explained by other potential aetiologies. Detailed
cardiac evaluations, including echocardiogram and

serum cardiac enzyme levels, need to be performed
as ECG abnormalities may not be demonstrated in
some cases. Early suspicion and supportive care are
essential to ensure a favourable outcome in paediatric
patients who suffer from this apparently ‘forgotten’
complication of mumps.
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